Fujitsu Healthy Living Implementation Guide
1.1.28 - release

Publication Build: This will be filled in by the publication tooling

Table of Contents

.. 0 Table of Contents
... 1 Home
... 2 Overview
... 3 UseCase
... 4 Guidance
... 5 Patient-Generated Health Data (PGHD)
... 6 Oncology
... 7 Release Notes
... 8 Artifacts Summary
.... 8.1 Fujitsu DocumentReference ($docref)
.... 8.2 FujitsuAppointmentEverything
.... 8.3 GAD-7 assesment
.... 8.4 PHQ-9 assesment
.... 8.5 Fujitsu Adverse Event Clinical Research
.... 8.6 Fujitsu AllergyIntolerance Profile
.... 8.7 Fujitsu Appointment Profile
.... 8.8 Fujitsu Cancer-Related Medication Administration Injection Profile
.... 8.9 Fujitsu Cancer-Related Medication Administration Profile
.... 8.10 Fujitsu Cancer-Related Medication Request Injection Profile
.... 8.11 Fujitsu Cancer-Related Medication Request Profile
.... 8.12 Fujitsu Cancer-Related Surgical Procedure Profile
.... 8.13 Fujitsu CarePlan Profile
.... 8.14 Fujitsu Condition Profile
.... 8.15 Fujitsu Consent Profile
.... 8.16 Fujitsu Device Profile
.... 8.17 Fujitsu DiagnosticReport LabResult Profile
.... 8.18 Fujitsu DocumentReference Profile
.... 8.19 Fujitsu Encounter Profile
.... 8.20 Fujitsu Genomics Report Profile
.... 8.21 Fujitsu HealthcareService Appointment Profile
.... 8.22 Fujitsu Immunization Profile
.... 8.23 Fujitsu Location Profile
.... 8.24 Fujitsu Medication Profile
.... 8.25 Fujitsu MedicationAdministration Injection Profile
.... 8.26 Fujitsu MedicationAdministration Insulin Profile
.... 8.27 Fujitsu MedicationAdministration Profile
.... 8.28 Fujitsu MedicationDispense Injection Profile
.... 8.29 Fujitsu MedicationDispense Profile
.... 8.30 Fujitsu MedicationRequest Injection Profile
.... 8.31 Fujitsu MedicationRequest Profile
.... 8.32 Fujitsu MedicationStatement Profile
.... 8.33 Fujitsu Observation Activity Profile
.... 8.34 Fujitsu Observation AlcholConsumption Profile
.... 8.35 Fujitsu Observation AlcholUse Profile
.... 8.36 Fujitsu Observation Audiogram Profile
.... 8.37 Fujitsu Observation BloodGlucose Profile
.... 8.38 Fujitsu Observation BloodPressure Profile
.... 8.39 Fujitsu Observation BMI Profile
.... 8.40 Fujitsu Observation Body Measurement Profile
.... 8.41 Fujitsu Observation BodyHeight Profile
.... 8.42 Fujitsu Observation BodyTemperature Profile
.... 8.43 Fujitsu Observation BodyWeight Profile
.... 8.44 Fujitsu Observation Cancer Disease Status Profile
.... 8.45 Fujitsu Observation Cancer Stage Profile
.... 8.46 Fujitsu Observation Cardiac Function Profile
.... 8.47 Fujitsu Observation CLL Binet Stage Profile
.... 8.48 Fujitsu Observation CLL Rai Stage Profile
.... 8.49 Fujitsu Observation Common Profile
.... 8.50 Fujitsu Observation Comorbidities Profile
.... 8.51 Fujitsu Observation Diving Profile
.... 8.52 Fujitsu Observation ECOG Performance Status Profile
.... 8.53 Fujitsu Observation Electrocardiogram Profile
.... 8.54 Fujitsu Observation Food Profile
.... 8.55 Fujitsu Observation Genomic Region Studied Profile
.... 8.56 Fujitsu Observation Genomic Variant Profile
.... 8.57 Fujitsu Observation Gynecologic Tumor FIGO Stage Profile
.... 8.58 Fujitsu Observation HeadCircum Profile
.... 8.59 Fujitsu Observation Hearing Profile
.... 8.60 Fujitsu Observation HearingSensitivity Profile
.... 8.61 Fujitsu Observation Heartbeat Profile
.... 8.62 Fujitsu Observation HeartRate Profile
.... 8.63 Fujitsu Observation History of Metastatic Cancer Profile
.... 8.64 Fujitsu Observation Karnofsky Performance Status Profile
.... 8.65 Fujitsu Observation LabResult Profile
.... 8.66 Fujitsu Observation Lymph Node Invasion Profile
.... 8.67 Fujitsu Observation Lymphoma Stage Profile
.... 8.68 Fujitsu Observation MedicationAdherence Profile
.... 8.69 Fujitsu Observation Melanoma Breslow Depth Stage Profile
.... 8.70 Fujitsu Observation Melanoma Clark Level Profile
.... 8.71 Fujitsu Observation MET by Standard RMR Profile
.... 8.72 Fujitsu Observation Microsatellite Instability Profile
.... 8.73 Fujitsu Observation Mindfulness Profile
.... 8.74 Fujitsu Observation Mobility Profile
.... 8.75 Fujitsu Observation Myeloma ISS Stage Profile
.... 8.76 Fujitsu Observation Myeloma RISS Stage Profile
.... 8.77 Fujitsu Observation Nutrition Profile
.... 8.78 Fujitsu Observation OxygenSaturation Profile
.... 8.79 Fujitsu Observation Parent for T, N, and M Categories Profile
.... 8.80 Fujitsu Observation Pregnancy Status Profile
.... 8.81 Fujitsu Observation Prostate Gleason Grade Group Profile
.... 8.82 Fujitsu Observation ReproductiveHealth Profile
.... 8.83 Fujitsu Observation RespiratoryRate Profile
.... 8.84 Fujitsu Observation Scored Assessment Profile
.... 8.85 Fujitsu Observation SelfCare Profile
.... 8.86 Fujitsu Observation Sleep Profile
.... 8.87 Fujitsu Observation SleepEpisode Profile
.... 8.88 Fujitsu Observation SnoreEvent Profile
.... 8.89 Fujitsu Observation SnoreIndex Profile
.... 8.90 Fujitsu Observation State of Mind Profile
.... 8.91 Fujitsu Observation Symptom Profile
.... 8.92 Fujitsu Observation TestResult Profile
.... 8.93 Fujitsu Observation TNM Distant Metastases Category Profile
.... 8.94 Fujitsu Observation TNM Primary Tumor Category Profile
.... 8.95 Fujitsu Observation TNM Regional Nodes Category Profile
.... 8.96 Fujitsu Observation TNM Stage Group Profile
.... 8.97 Fujitsu Observation Tumor Marker Test Profile
.... 8.98 Fujitsu Observation Tumor Mutation Burden Profile
.... 8.99 Fujitsu Observation Tumor Size Profile
.... 8.100 Fujitsu Observation UVExposure Profile
.... 8.101 Fujitsu Observation Vital Signs Profile
.... 8.102 Fujitsu Observation VoltageMeasurement Profile
.... 8.103 Fujitsu Observation Workout Profile
.... 8.104 Fujitsu Oncology Patient Group Profile
.... 8.105 Fujitsu Oncology Specimen Profile
.... 8.106 Fujitsu Organization Profile
.... 8.107 Fujitsu Patient Profile
.... 8.108 Fujitsu Practitioner Profile
.... 8.109 Fujitsu PractitionerRole Profile
.... 8.110 Fujitsu Primary Cancer Condition Profile
.... 8.111 Fujitsu Procedure Profile
.... 8.112 Fujitsu Questionnaire Profile
.... 8.113 Fujitsu QuestionnaireResponse Profile
.... 8.114 Fujitsu Radiotherapy Course Summary Profile
.... 8.115 Fujitsu Radiotherapy Volume Profile
.... 8.116 Fujitsu Secondary Cancer Condition Profile
.... 8.117 Fujitsu SelfCare Plan Profile
.... 8.118 Fujitsu Specimen Profile
.... 8.119 Fujitsu Tumor Profile
.... 8.120 Fujitsu Body Structure Identifier Profile
.... 8.121 Fujitsu Adverse event caused subject to discontinue the study
.... 8.122 Fujitsu Adverse Event Grade
.... 8.123 Fujitsu Adverse Event resolution date
.... 8.124 Fujitsu Body Location Qualifier Extension
.... 8.125 Fujitsu Body Location Qualifier Extension
.... 8.126 Fujitsu Contributing Factor
.... 8.127 Fujitsu Criteria reviewed in determining serious adverse event
.... 8.128 Fujitsu elated Condition Absent Extension
.... 8.129 Fujitsu Expected In Research Study
.... 8.130 Fujitsu HeartRate Rhythm Extension
.... 8.131 Fujitsu Histology Morphology Behavior Extension
.... 8.132 Fujitsu Hours After Meal Extension
.... 8.133 Fujitsu Mitigating Action
.... 8.134 Fujitsu Note
.... 8.135 Fujitsu Participant
.... 8.136 Fujitsu Procedure Intent Extension
.... 8.137 Fujitsu Radiotherapy Dose Delivered To Volume Extension
.... 8.138 Fujitsu Radiotherapy Modality And Technique Extension
.... 8.139 Fujitsu Radiotherapy Modality Extension
.... 8.140 Fujitsu Radiotherapy Number of Sessions Extension
.... 8.141 Fujitsu Radiotherapy Technique Extension
.... 8.142 Fujitsu Related Condition Extension
.... 8.143 Fujitsu Relationship To Physical Ativity Extension
.... 8.144 Fujitsu Relationship To Sleep Extension
.... 8.145 Fujitsu Research Subject record of subject
.... 8.146 Fujitsu Resulting Effect
.... 8.147 Fujitsu Supporting information relevant to the event
.... 8.148 Fujitsu Suspect Entity
.... 8.149 Fujitsu Treatment Termination Reason Extension
.... 8.150 Fujitsu Workflow Status
.... 8.151 Benign Neoplasm of Brain and CNS Disorder ValueSet
.... 8.152 Body Location And Laterality Qualifier ValueSet
.... 8.153 Body Location Qualifier ValueSet
.... 8.154 Body Temperature Measurement Location Codes
.... 8.155 Cancer Body Location ValueSet
.... 8.156 Cancer Disorder ValueSet
.... 8.157 Cancer Stage ValueSet
.... 8.158 Cancer Staging Method ValueSet
.... 8.159 Cancer Staging Type ValueSet
.... 8.160 Carcinoma In-Situ Disorder ValueSet
.... 8.161 Clark Level ValueSet
.... 8.162 Condition BodySite Codes
.... 8.163 Condition Codes
.... 8.164 Condition Status Trend ValueSet
.... 8.165 ECG Classification Codes
.... 8.166 ECG Lead Codes
.... 8.167 ECG Lead Codes
.... 8.168 ECG Symptoms Status Codes
.... 8.169 FIGO Stage ValueSet
.... 8.170 FIGO Staging Method ValueSet
.... 8.171 FIGO Staging Method ValueSet
.... 8.172 FIGO Staging Method ValueSet
.... 8.173 Fujitsu Internal Identifier URI
.... 8.174 Fujitsu Medication Unit MERIT9
.... 8.175 Fujitsu UCUM
.... 8.176 Gleason Grade ValueSet
.... 8.177 Histology Morphology Behavior ValueSet
.... 8.178 History of Metastatic Malignant Neoplasm ValueSet
.... 8.179 International Staging System (ISS) for Myeloma Stage ValueSet
.... 8.180 Laterality Qualifier ValueSet
.... 8.181 Lymphoma Stage ValueSet
.... 8.182 Lymphoma Staging System ValueSet
.... 8.183 Medication Method Injection Codes
.... 8.184 Medication Method Prescription Codes
.... 8.185 Melanoma In-Situ Disorder ValueSet
.... 8.186 Morphology ValueSet
.... 8.187 Observation Activity Codes
.... 8.188 Observation AlcholConsumption Codes
.... 8.189 Observation BloodGlucose Codes
.... 8.190 Observation BodyMesurements Codes
.... 8.191 Observation Diving Codes
.... 8.192 Observation GAD7 Risk Codes
.... 8.193 Observation Hearing Codes
.... 8.194 Observation LabResults Codes
.... 8.195 Observation Mind Codes
.... 8.196 Observation Mindfulness Codes
.... 8.197 Observation Mobility Codes
.... 8.198 Observation Nutrition Codes
.... 8.199 Observation PHQ9Risk Codes
.... 8.200 Observation ReproductiveHealth Codes
.... 8.201 Observation Scored Assessment Codes
.... 8.202 Observation SelfCare Codes
.... 8.203 Observation Sleep Codes
.... 8.204 Observation State of Mind Association Codes
.... 8.205 Observation State of Mind Codes
.... 8.206 Observation State of Mind Codes
.... 8.207 Observation State of Mind Kind Codes
.... 8.208 Observation State of Mind Label Codes
.... 8.209 Observation State of Mind Valence Codes
.... 8.210 Observation Symptom Codes
.... 8.211 Observation UVExposure Codes
.... 8.212 Observation Vitalsigns Codes
.... 8.213 Observation Workout Codes
.... 8.214 Performance Status ValueSet
.... 8.215 Primary Cancer Disorder ValueSet
.... 8.216 Primary Malignant Neoplasm Disorder ValueSet
.... 8.217 Procedure Intent Qualifier ValueSet
.... 8.218 Radiotherapy Modality ValueSet
.... 8.219 Radiotherapy Technique ValueSet
.... 8.220 Radiotherapy Treatment Location Qualifier ValueSet
.... 8.221 Radiotherapy Treatment Location ValueSet
.... 8.222 Radiotherapy Volume Type ValueSet
.... 8.223 Rai Stage ValueSet
.... 8.224 Rai Staging System ValueSet
.... 8.225 Revised International Staging System (RISS) for Myeloma Stage ValueSet
.... 8.226 Secondary Cancer Disorder ValueSet
.... 8.227 Sleep Analysis
.... 8.228 Source for Adjusted MET Codes
.... 8.229 Source for Estimated MET Codes
.... 8.230 Source for Reported MET Codes
.... 8.231 Specific Diagnosis of Cancer ValueSet
.... 8.232 Specimen Codes
.... 8.233 Symptom Appetite Changes
.... 8.234 Symptom Presence
.... 8.235 Symptom Severity
.... 8.236 Temporal relationship to physical activity Codes
.... 8.237 Temporal relationship to sleep Codes
.... 8.238 TNM Distant Metastases Category ValueSet
.... 8.239 TNM Distant Metastases Staging Type ValueSet
.... 8.240 TNM Primary Tumor Category ValueSet
.... 8.241 TNM Primary Tumor Staging Type ValueSet
.... 8.242 TNM Regional Nodes Category Staging Type ValueSet
.... 8.243 TNM Regional Nodes Category ValueSet
.... 8.244 TNM Stage Group Staging Type ValueSet
.... 8.245 TNM Stage Group ValueSet
.... 8.246 TNM Staging Method ValueSet
.... 8.247 Treatment Termination Reason ValueSet
.... 8.248 Tumor Marker Test ValueSet
.... 8.249 Tumor Size Method ValueSet
.... 8.250 UCUM Body Length Units
.... 8.251 UCUM Body Temprature Units
.... 8.252 UCUM Body Weight Units
.... 8.253 UCUM Vital Signs Units
.... 8.254 Vital Signs Loinc Codes
.... 8.255 Appetite Changes Codes
.... 8.256 Body Posture Codes
.... 8.257 Body Temperature Measurement Location Codes
.... 8.258 Cancer Stage
.... 8.259 Cancer Staging Method
.... 8.260 Cancer Staging Type
.... 8.261 Clark Level ValueSet
.... 8.262 Condition BodySite Codes
.... 8.263 Condition BodySite Qualifier Codes
.... 8.264 Condition Status Trend Codes
.... 8.265 ECG Classification Codes
.... 8.266 ECG Classification Codes
.... 8.267 ECG Lead Codes
.... 8.268 ECG Symptoms Status Codes
.... 8.269 FIGO Stage
.... 8.270 FIGO Staging Method
.... 8.271 FIGO Staging Method
.... 8.272 FIGO Staging Method
.... 8.273 Fujitsu Internal Identifier URI
.... 8.274 GAD-7 Assesment Risk Codes
.... 8.275 Gleason Grade ValueSet
.... 8.276 Hearing Sensitivity Codes
.... 8.277 History of Metastatic Malignant Neoplasm ValueSet
.... 8.278 ICD-O-3
.... 8.279 ICD10 Codes
.... 8.280 International Staging System (ISS) for Myeloma Stage ValueSet
.... 8.281 JLAC10 Specimen Codes
.... 8.282 Loinc Codes
.... 8.283 Lymphoma Stage ValueSet
.... 8.284 Lymphoma Staging System ValueSet
.... 8.285 Observation PHR Codes
.... 8.286 PHQ-9 Assesment Risk Codes
.... 8.287 Procedure Intent Qualifier ValueSet
.... 8.288 Radiotherapy Modality Codes
.... 8.289 Radiotherapy Modality Codes
.... 8.290 Radiotherapy Treatment Location Qualifier ValueSet
.... 8.291 Radiotherapy Volume Type Codes
.... 8.292 Rai Stage ValueSet
.... 8.293 Rai Staging System
.... 8.294 Revised International Staging System (RISS) for Myeloma Stage ValueSet
.... 8.295 Scored Assessment Codes
.... 8.296 Sleep Analysis Codes
.... 8.297 Sleep Episode Codes
.... 8.298 Snore Event Item Codes
.... 8.299 State of Mind Association Codes
.... 8.300 State of Mind Codes
.... 8.301 State of Mind Kind Codes
.... 8.302 State of Mind Label Codes
.... 8.303 State of Mind Valence Codes
.... 8.304 Symptom Presence Codes
.... 8.305 Symptom Severity Codes
.... 8.306 Temporal relationship to physical activity
.... 8.307 Temporal relationship to sleep
.... 8.308 TNM Distant Metastases Category
.... 8.309 TNM Primary Tumor Category
.... 8.310 TNM Regional Nodes Category
.... 8.311 TNM Stage Group
.... 8.312 TNM Staging Method
.... 8.313 Treatment Termination Reason ValueSet
.... 8.314 Tumor Size Method ValueSet
.... 8.315 UCUM Codes
.... 8.316 (K0771)FLU/CY
.... 8.317 adverse-event-compass-ex1
.... 8.318 adverse-event-compass-ex1a
.... 8.319 adverse-event-compass-ex1b
.... 8.320 adverse-event-compass-ex2
.... 8.321 adverse-event-device-death
.... 8.322 AdverseEventFromProcedureNotStudyDrug
.... 8.323 AEHeadache
.... 8.324 AEHepaticFailure
.... 8.325 AEHepaticFailurecomplication
.... 8.326 AEModeratehives
.... 8.327 AllergyIntoleranceExample
.... 8.328 AppointmentExample
.... 8.329 BloodPressureExample
.... 8.330 BMIExample
.... 8.331 BMIExample1
.... 8.332 BodyHeightExample
.... 8.333 BodyHeightExample1
.... 8.334 BodyStructureTumorExample
.... 8.335 BodyTemperatureExample
.... 8.336 BodyTemperatureExample1
.... 8.337 BodyTemperatureExample2
.... 8.338 BodyWeightExample
.... 8.339 BodyWeightExample1
.... 8.340 Breast Cancer Trial
.... 8.341 clinical-trial-acme-procedure
.... 8.342 clinical-trial-acme-subject
.... 8.343 clinical-trial-example-compass
.... 8.344 clinical-trial-example-subject
.... 8.345 clinical-trial-example-subject1
.... 8.346 ClinicalTrialSignificantAdverseEvent
.... 8.347 ClinicalTrialSubject5
.... 8.348 ComorbiditiesExample
.... 8.349 ConditionAbsentExample
.... 8.350 ConditionExample
.... 8.351 ConditionPrimaryCancerExample
.... 8.352 ConditionSecondaryCancerExample
.... 8.353 ConsentExample
.... 8.354 Device - Infuser that exploded
.... 8.355 DeviceExample
.... 8.356 DiagnosticReportGenomicsReportExample
.... 8.357 DocumentReferenceExample
.... 8.358 EKGExample
.... 8.359 EncounterDummyCaseExample
.... 8.360 EncounterHospitalizationExample
.... 8.361 EncounterOutpatientCaseExample
.... 8.362 Example patient SLP
.... 8.363 FujitsuHealthcareServiceExample
.... 8.364 GIBleed
.... 8.365 HeadCircumExample
.... 8.366 HeartRateExample
.... 8.367 HeartRateExample1
.... 8.368 HeartRateExample2
.... 8.369 HeartRateExample3
.... 8.370 HeartRateExample4
.... 8.371 HistoryOfMetastaticCancerExample
.... 8.372 ImmunizationExample
.... 8.373 ImmunizationOccurrenceAbsentExample
.... 8.374 Janet allergy med
.... 8.375 Janet Blood Pressure Observation
.... 8.376 Janet Patient
.... 8.377 Janet pill for water retention med not known
.... 8.378 Janet Tylenol PM med
.... 8.379 Janet weight Observation
.... 8.380 LabResultAbsentExample
.... 8.381 LabResultExample
.... 8.382 LabResultExample2
.... 8.383 LocationExample
.... 8.384 Medication Administration for bresentrik
.... 8.385 Medication Administration of Med0301
.... 8.386 Medication is bresentrik
.... 8.387 Medication Request for bresentrik
.... 8.388 Medication Request for discontinued clinical trial medication 0301
.... 8.389 Medication Request for discontinued clinical trial medication ABC
.... 8.390 medication-administration-contrast-dye
.... 8.391 medication-administration-forhives
.... 8.392 medication-administration-kadcyla
.... 8.393 medication-administration-kadcyla-reduced
.... 8.394 medication-administration-kadcyla1
.... 8.395 medication-administration-tucatinib
.... 8.396 medication-administration-tucatinib-reduced
.... 8.397 medication-administration-tylenol
.... 8.398 medication-request-example-kadcyla
.... 8.399 medication-request-example-kadcyla1
.... 8.400 medication-request-example-tucatinib
.... 8.401 medication-request-example-zofran
.... 8.402 MedicationAdministrationCancerRelatedExample
.... 8.403 MedicationAdministrationExample
.... 8.404 MedicationAdministrationInjectionExample
.... 8.405 MedicationAdministrationInsulinExample-1
.... 8.406 MedicationAdministrationInsulinExample-2
.... 8.407 MedicationDispenseExample1
.... 8.408 MedicationDispenseInjectionExample
.... 8.409 MedicationRequestCancerRelatedInjectionExample
.... 8.410 MedicationRequestExample
.... 8.411 MedicationRequestExample2
.... 8.412 MedicationRequestInjectionExample
.... 8.413 MedicationStatementExample
.... 8.414 MedicationUnitAbsentExample
.... 8.415 NonSeriousAdverseEventResearchStudyMed
.... 8.416 ObservationActivityDistanceExample1
.... 8.417 ObservationActivityElevationGainedExample1
.... 8.418 ObservationActivityExample
.... 8.419 ObservationActivityMetByStandardRmrExample1
.... 8.420 ObservationActivityMetByStandardRmrExample2
.... 8.421 ObservationActivityMetExample
.... 8.422 ObservationActivityModerateActivityExample1
.... 8.423 ObservationActivityModerateToVigorousActivityExample
.... 8.424 ObservationActivityPaceExample
.... 8.425 ObservationActivityRunningSpeedExample1
.... 8.426 ObservationActivityStepCountExample
.... 8.427 ObservationActivityStepCountExample1
.... 8.428 ObservationActivityStepsCadenceExample1
.... 8.429 ObservationActivityTotalEnergyBurnedExample
.... 8.430 ObservationActivityTotalEnergyBurnedExample1
.... 8.431 ObservationActivityVigorousActivityExample1
.... 8.432 ObservationAlcholConsumptionExample
.... 8.433 ObservationAlcholUseExample
.... 8.434 ObservationAudiogramExample
.... 8.435 ObservationBloodGlucoseExample1
.... 8.436 ObservationBloodGlucoseExample2
.... 8.437 ObservationBloodGlucoseExample3
.... 8.438 ObservationBodyFatPercentageExample
.... 8.439 ObservationCardiacFunctionRrIntervalExample
.... 8.440 ObservationCLLBinetStageExample
.... 8.441 ObservationCLLRaiStageExample
.... 8.442 ObservationDivingExample
.... 8.443 ObservationElectrocardiogramExample
.... 8.444 ObservationFoodExample
.... 8.445 ObservationGenomicRegionStudiedExample
.... 8.446 ObservationGenomicVariantExample
.... 8.447 ObservationGynecologicTumorFIGOStageExample
.... 8.448 ObservationHearingExample
.... 8.449 ObservationHearingSensitivity1000Example
.... 8.450 ObservationHearingSensitivity2000Example
.... 8.451 ObservationHearingSensitivity250Example
.... 8.452 ObservationHearingSensitivity4000Example
.... 8.453 ObservationHearingSensitivity500Example
.... 8.454 ObservationHearingSensitivity8000Example
.... 8.455 ObservationLowHeartRateEventExample
.... 8.456 ObservationLymphomaStageExample
.... 8.457 ObservationMedicationAdherenceExample
.... 8.458 ObservationMelanomaBreslowDepthStageExample
.... 8.459 ObservationMelanomaClarkLevelExample
.... 8.460 ObservationMindfulnessExample
.... 8.461 ObservationMobilityExample
.... 8.462 ObservationMyelomaISSStageExample
.... 8.463 ObservationMyelomaRISSStageExample
.... 8.464 ObservationNutritionDietaryCarbohydratesExample1
.... 8.465 ObservationNutritionDietaryCarbohydratesExample2
.... 8.466 ObservationNutritionDietaryEnergyConsumedExample1
.... 8.467 ObservationNutritionDietaryEnergyConsumedExample2
.... 8.468 ObservationNutritionExample
.... 8.469 ObservationPregnancyExample
.... 8.470 ObservationProstateGleasonGradeGroupExample
.... 8.471 observationReproductiveHealthIntermenstrualBleeding
.... 8.472 ObservationRespiratoryBreathCarbonMonoxideExample
.... 8.473 ObservationRespiratoryInspiratoryTimeExample
.... 8.474 ObservationRespiratoryMinuteVolumeExample
.... 8.475 ObservationRespiratoryVentilationCycleTimeExample
.... 8.476 ObservationSelfCareExample
.... 8.477 ObservationSleepAhiExample
.... 8.478 ObservationSleepArousalIndexExample
.... 8.479 ObservationSleepEpisodeCoreSleepExample1
.... 8.480 ObservationSleepEpisodeCoreSleepExample2
.... 8.481 ObservationSleepEpisodeDeepSleepExample1
.... 8.482 ObservationSleepEpisodeDeepSleepExample2
.... 8.483 ObservationSleepEpisodeExample1
.... 8.484 ObservationSleepEpisodeExample2
.... 8.485 ObservationSleepEpisodeLatencyToSleepOnsetExample1
.... 8.486 ObservationSleepEpisodeLatencyToSleepOnsetExample2
.... 8.487 ObservationSleepExample
.... 8.488 ObservationSnoreEventExample1
.... 8.489 ObservationSnoreEventExample2
.... 8.490 ObservationSnoreEventExample3
.... 8.491 ObservationSnoreIndexExample1
.... 8.492 ObservationSnoreIndexExample2
.... 8.493 ObservationSymptomExample
.... 8.494 ObservationTNMDistantMetastasesCategoryExample
.... 8.495 ObservationTNMPrimaryTumorCategoryExample
.... 8.496 ObservationTNMRegionalNodesCategoryExample
.... 8.497 ObservationTNMStageGroupExample
.... 8.498 ObservationTumorMarkerTestExample
.... 8.499 ObservationTumorSizeExample
.... 8.500 ObservationUVExposureExample
.... 8.501 ObservationVoltageMeasurementExample
.... 8.502 ObservationWorkoutJumpRopeExample
.... 8.503 ObservationWorkoutRunningExample
.... 8.504 OperationAbsentExample
.... 8.505 OperationExample
.... 8.506 OrganizationExample
.... 8.507 OxygenSaturationExample
.... 8.508 Patient MOUMIC
.... 8.509 Patient reported AE during research study
.... 8.510 patient-example-kaitlyn-b
.... 8.511 patient-example-kaitlyn-b1
.... 8.512 PatientExample
.... 8.513 PerformanceStatusKarnofskyExample
.... 8.514 phr-heartbeat
.... 8.515 practitioner-oncology-nurse-jane
.... 8.516 practitioner-owen-oncologist
.... 8.517 PractitionerExample
.... 8.518 PractitionerRoleExample
.... 8.519 Problem
.... 8.520 procedure-upper-endoscopy
.... 8.521 Provenance for Janet Blood Pressure Observation
.... 8.522 Provenance for Janet weight Observation
.... 8.523 QuestionnaireResponseExample
.... 8.524 QuestionnaireResponseScoredAssessmentGAD7Example
.... 8.525 QuestionnaireResponseScoredAssessmentPHQ9Example
.... 8.526 RadiationTherapyAbsentExample
.... 8.527 RadiationTherapyExample
.... 8.528 RadiotherapyCourseSummaryExample
.... 8.529 RadiotherapyVolumeExample
.... 8.530 research-study-acme
.... 8.531 research-study-DISNEY
.... 8.532 research-study-XYZ
.... 8.533 RespiratoryRateExample
.... 8.534 RespiratoryRateExample1
.... 8.535 RespiratoryRateExample2
.... 8.536 RespiratoryRateExample3
.... 8.537 ScoredAssessmentGAD7Example
.... 8.538 ScoredAssessmentPHQ9Example
.... 8.539 Serious Adverse Event
.... 8.540 SeriousAdverseEventResearchStudy
.... 8.541 SpecimenAbsentExample
.... 8.542 SpecimenExample
.... 8.543 SpecimenOncologyExample
.... 8.544 StateOfMind2Example
.... 8.545 StateOfMindExample
.... 8.546 study-medication-administration-ABC
.... 8.547 study-medication-administration-MMD
.... 8.548 study-medication-administration-WBY
.... 8.549 SurgicalProcedureCancerRelatedExample
.... 8.550 仕事と機能能力の自己評価
.... 8.551 腰痛や怪我
.... 8.552 腰痛や怪我